Sorry, you need to enable JavaScript to visit this website.
  1. Home
  2. Our Science
  3. Clinical Trials
  4. Plain Language Study Results Summaries

Plain Language Study Results Summaries

What Are Plain Language Study Results Summaries?

Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries, also called plain language summaries, simple summaries, and trial results summaries, are intended to make clinical results understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.

Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials.

Filter Results

Refine your search results by using the dropdown filters below. Click “reset” to return to the full list of available studies.

A Study to Learn How the Body Processes Spironolactone and Hydrochlorothiazide Film Coated Tablets Manufactured at Two Sites: Viatris and Neolpharma
Category & Conditions: Cardiovasular Diseases and Conditions
Study Phase : 1
Medicine: ALDACTAZIDE®(SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE)
Language: English
ViewDownloadPrint
A Study of Avelumab Maintenance Treatment in Patients With Locally Advanced or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
Category & Conditions: Cancer
Study Phase : 3
Medicine: BAVENCIO(AVELUMAB)
Language: English
ViewDownloadPrint
Avelumab in Previously Untreated Patients with Epithelial Ovarian Cancer (Javelin Ovarian 100)
Category & Conditions: Cancer
Study Phase : 3
Medicine: BAVENCIO(AVELUMAB)
Language: English
ViewDownloadPrint
A study of Avelumab with Axitinib Versus Sunitinib in Advanced Renal Cell Cancer (JAVELIN Renal 101)
Category & Conditions: Cancer
Study Phase : 3
Medicine: BAVENCIO(AVELUMAB)
Language: English
ViewDownloadPrint
Study to Evaluate the Safety of Combinations of Avelumab, Binimetinib and Talazoparib in Patients With Advanced Cancer
Category & Conditions: Cancer
Study Phase : 1/2
Medicine: BAVENCIO(AVELUMAB), MEKTOVI® TABLETS(BINIMETINIB), Talzenna (talazoparib)
Language: English
ViewDownloadPrint
A Study of Two Inotuzumab Ozogamicin (InO) Doses in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Transplant Eligible Patients
Category & Conditions: Cancer
Study Phase : 4
Medicine: BESPONSA™ FOR INJECTION(INOTUZUMAB OZOGAMICIN)
Language: English
ViewDownloadPrint
Bioavailability of Bosutinib Administered as Capsule Contents Mixed With Applesauce or Yogurt Compared to Intact Capsules Under Fed Condition
Category & Conditions: Cancer
Study Phase : 1
Medicine: BOSULIF®(BOSUTINIB)
Language: English
ViewDownloadPrint
Bioavailability of Bosutinib Capsules and the Effect of Food on Bosutinib Capsule
Category & Conditions: Cancer
Study Phase : 1
Medicine: BOSULIF®(BOSUTINIB)
Language: English
ViewDownloadPrint
A Multicenter Phase 3 Randomized, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (Bosutinib trial in First line chrOnic myelogenous leukemia tREatment; BFORE)
Category & Conditions: Cancer
Study Phase : 3
Medicine: BOSULIF®(BOSUTINIB)
Language: English
ViewDownloadPrint
A Phase 1, Multicenter, Open-label, Dose-escalation Study of Oral LGX818 in Adult Patients With Locally Advanced or Metastatic BRAF Mutant Melanoma
Category & Conditions: Cancer
Study Phase : 1
Medicine: BRAFTOVI® CAPSULES(ENCORAFENIB)
Language: English
ViewDownloadPrint
A study of two new encorafenib formulations and the effect of a proton-pump inhibitor on these formulations in adult healthy participants
Category & Conditions: Cancer
Study Phase : 1
Medicine: BRAFTOVI® CAPSULES(ENCORAFENIB)
Language: English
ViewDownloadPrint
A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients (BRIGHT 1012)
Category & Conditions: Cancer
Study Phase : 1
Medicine: DAURISMO TABLETS(GLASDEGIB)
Language: English
ViewDownloadPrint